AIM Rule 26

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 global pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail.

With more than 2,500 employees the Group is active in Ireland, UK, Benelux., Nordics and USA

Names of Directors and Biographical Details

For information on the Board of Directors and Biographical Details.

View Our Board of Directors

Board Committees

For information on the Audit and Risk Committee, Remuneration Committee and Nomination Committee.

View Committees Here

Country of Incorporation and Main Country of Operation

Uniphar Group plc is incorporated and headquartered in Ireland (Company registration number: 224324).

The Group’s main operations are from its facilities in:

4045 Kingswood Road, Citywest Business Park, County Dublin, Ireland.

The rights of shareholders in an Irish incorporated company may be different from the rights of shareholders in a UK incorporated company.

Nominated Adviser and Other Key Advisers

Please click on the link for information of the Company’s Nominated Adviser and other key advisers, including contact details, which will be investor contacts.

View Advisers here

Company Announcement

Please click on the link to access the notifications made by the Company in the past 12 months.

View Investor News

Financial Information

Please click on the link for access to the Company’s annual and interim reports.

View Results and Presentations here.

Admission Documents

Please click on the link to access the Company’s Admission Document.

View our Admission Document here

Details of Any Other Exchanges or Trading Platforms

The company's shares are listed on the AIM and Euronext Growth markets of the London Stock Exchange and Euronext Dublin, respectively.

Number of Securities in Issue

Ordinary Shares in issue: 273,015,254

Significant Shareholders information:

Shareholder Ordinary Shares held % shareholding
Polar Capital 19,116,145 7.0%
MacKenzie Financial Corporation 17,374,939 6.4%
Sisk Family 16,152,373 5.9%
Allianz Global Investors 11,270,000 4.1%
Gerard Rabbette (1) 8,758,310 3.2%

(1) Including Ordinary Shares issued under the 2018 LTIP

Details of Any Restrictions on the Transfer of Securities

There are no restrictions on the transfer of securities.

Whether the Company is subject to the UK City Code on Takeovers and Mergers

There are no restrictions on the transfer of securities.